John Karalis

8PUBLICATIONS
20CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples religion and religious studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 13, 2025
The Current State of Tumor Microenvironment-Specific Therapies for Non-Small Cell Lung Cancer.

Raghav Chandra, Jasmina Ehab, Edward Hauptmann

|Sep 29, 2023
ASO Author Reflections: Novel Methodology to Define High-Volume Centers for Complex Cancer Operations.

John D Karalis, Michelle R Ju, Matthew R Porembka

|May 27, 2023
Factors associated with failure to operate and its impact on survival in early-stage pancreatic cancer.

Gilbert Z Murimwa, John D Karalis, Jennie Meier

|Dec 12, 2022
ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer.

Sunho Park, John D Karalis, Changjin Hong

|Mar 08, 2022
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.

John D Karalis, Lynn Y Yoon, Suntrea T G Hammer

|Dec 24, 2021
The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis.

Raghav Chandra, John D Karalis, Charles Liu

Pageof 2

Frequent Collaborators

3 joint publications

Matthew R Porembka

3 joint publications

Sam C Wang

2 joint publications

Rolf A Brekken

1 joint publications

Charles Liu